QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Los Angeles, CA -- (SBWire) -- 02/09/2019 --Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.

Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.

Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.

North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.

This report focuses on Cancer Treatment Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Treatment Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Get PDF report template: https://www.qyresearch.com/sample-form/form/960052/global-cancer-treatment-drugs-competition-analysis

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

    Roche

    Novartis

    Celgene

    Bristol-Myers Squibb

    Amgen

    Johnson & Johnson

    Pfizer

    Takeda

    Eli Lilly

    AstraZeneca

    Astellas

    Merck & Co.

    Sanofi

    Bayer

    Biogen Idec

    Eisai

    Teva

    Otsuka

    Merck KGaA

    Ipsen

    AbbVie

    Gilead Sciences

Segment by Regions

    North America

    Europe

    China

    Japan

Segment by Type

    Chemotherapy

    Targeted Therapy

    Immunotherapy

    Hormonal Therapy (Biologic Therapy)

    Others

Segment by Application

    Blood Cancer

    Breast Cancer

    Gastrointestinal Cancer

    Prostate Cancer

    Respiratory/Lung Cancer

    Other Cancers

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

Access Full Comprehensive Industry Insights: https://www.qyresearch.com/settlement/pre/2eeffd0c3147240d3aa72e27cbce3bdc,0,1,Global%20Cancer%20Treatment%20Drugs%20Competition%20Analysis%202019
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.